Attached files
file | filename |
---|---|
8-K - QUEST DIAGNOSTICS INC | c63037_8k.htm |
EX-99.1 - QUEST DIAGNOSTICS INC | c63037_ex99-1.htm |
Exhibit 99.2
QUEST DIAGNOSTICS INCREASES SHARE REPURCHASE
AUTHORITY
BY $250 MILLION
BY $250 MILLION
MADISON, N.J.,
October 20, 2010 Quest Diagnostics Incorporated (NYSE: DGX), the worlds leading provider
of diagnostic testing, information and services, announced that its Board of Directors
increased the companys share repurchase authorization by $250 million.
During the first three quarters of 2010, the company repurchased approximately 15 million shares of common stock for $750 million, fully utilizing its previous authorization, which was granted in January, 2010. The company had approximately 170 million shares outstanding as of September 30, 2010.
About Quest
Diagnostics
Quest Diagnostics is the
worlds leading provider of diagnostic testing, information and services that
patients and doctors need to make better healthcare decisions. The company
offers the broadest access to diagnostic testing services through its network
of laboratories and patient service centers, and provides interpretive
consultation through its extensive medical and scientific staff. Quest
Diagnostics is a pioneer in developing innovative diagnostic tests and advanced
healthcare information technology solutions that help improve patient care.
# # #